These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11819967)

  • 1. What a difference a day makes.
    Huff B
    GMHC Treat Issues; 2001; 15(11-12):15. PubMed ID: 11819967
    [No Abstract]   [Full Text] [Related]  

  • 2. Stavudine (Zerit).
    Res Initiat Treat Action; 2000 Mar; 6(1):12-3. PubMed ID: 11708176
    [No Abstract]   [Full Text] [Related]  

  • 3. d4T plus ddI: warning for pregnant women.
    AIDS Treat News; 2001 Jan; (358):8. PubMed ID: 12173560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients.
    Reliquet V; Ferré V; Hascoet C; Besnier JM; Bellein V; Arvieux C; Molina JM; Breux JP; Zucman D; Rozenbaum W; Allavena C; Raffi F;
    Antivir Ther; 1999; 4 Suppl 3():83-4. PubMed ID: 16021876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New uses for tenofovir: more questions about d4T.
    Proj Inf Perspect; 2003 Jan; (35):15-6. PubMed ID: 12647676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stavudine-induced macrocytosis during therapy for human immunodeficiency virus infection.
    Martin GJ; Blazes DL; Mayers DL; Spooner KM
    Clin Infect Dis; 1999 Aug; 29(2):459-60. PubMed ID: 10476771
    [No Abstract]   [Full Text] [Related]  

  • 7. Stavudine in antiretroviral therapy: is this the end?
    Brinkman K
    AIDS; 2009 Aug; 23(13):1727-9. PubMed ID: 19571724
    [No Abstract]   [Full Text] [Related]  

  • 8. New questions about an old combination--ddI + d4T.
    Proj Inf Perspect; 2003 Jan; (35):13-4. PubMed ID: 12647675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side effects and complications. Does switching therapy away from d4T help the face?
    TreatmentUpdate; 2005 Dec; 17(7):2-3. PubMed ID: 17223668
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tenofovir in Study 903. Also effective and tolerable in first-line therapy].
    MMW Fortschr Med; 2002 Aug; 144(33-34):61. PubMed ID: 12380158
    [No Abstract]   [Full Text] [Related]  

  • 11. Tenofovir drug interactions: ddI and d4T.
    TreatmentUpdate; 2003; 15(2):7. PubMed ID: 12693363
    [No Abstract]   [Full Text] [Related]  

  • 12. Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
    Prescrire Int; 2004 Oct; 13(73):180-2. PubMed ID: 15499699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
    Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
    Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of chronic hepatitis C in patients coinfected with HIV: tolerability, drug interactions, therapeutic indications].
    Perronne C
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B274-82. PubMed ID: 12180301
    [No Abstract]   [Full Text] [Related]  

  • 15. Stavudine, lamivudine plus novel protease inhibitor therapy in antiretroviral-naive HIV-infected individuals treated for 24 weeks.
    Murphy RL
    Antivir Ther; 1999; 4 Suppl 3():85-7. PubMed ID: 16021877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA notifications. FDA grants tentative approval to two ART drugs under expedited review.
    AIDS Alert; 2007 May; 22(5):57. PubMed ID: 17580369
    [No Abstract]   [Full Text] [Related]  

  • 17. Lamivudine 300 mg in HIV infection: dose change. Once-a-day dosing.
    Prescrire Int; 2004 Apr; 13(70):54. PubMed ID: 15148972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature.
    Rossero R; Asmuth DM; Grady JJ; McKinsey DS; Green S; Andron L; Pollard RB
    Int J STD AIDS; 2003 May; 14(5):350-5. PubMed ID: 12803944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA notifications. FDA approves generic stavudine.
    AIDS Alert; 2009 Mar; 24(3):34. PubMed ID: 19441156
    [No Abstract]   [Full Text] [Related]  

  • 20. Final analysis of stavudine.
    AIDS Patient Care; 1995 Oct; 9(5):257. PubMed ID: 11361414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.